Stifel Nicolaus Issues Positive Forecast for Hinge Health (NYSE:HNGE) Stock Price

Key Points

• Stifel Nicolaus raised its target price for Hinge Health's stock from $63.00 to $66.00, signaling a potential upside of 14.68% from its previous close.
• Other analysts have also issued favorable ratings, with a consensus of fifteen 'Buy' ratings and two 'Hold' ratings, resulting in a consensus target price of $56.47.
• The stock opened at $57.55 on Thursday, reflecting its twelve-month range of a low of $33.42 and a high of $62.18.

Hinge Health (NYSE:HNGE - Get Free Report) had its target price hoisted by analysts at Stifel Nicolaus from $63.00 to $66.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage presently has a "buy" rating on the stock. Stifel Nicolaus' target price points to a potential upside of 14.68% from the company's previous close.

A number of other equities analysts also recently weighed in on the company. Wall Street Zen upgraded Hinge Health to a "hold" rating in a report on Monday, June 2nd. KeyCorp increased their price objective on Hinge Health from $45.00 to $60.00 and gave the stock an "overweight" rating in a report on Monday, July 14th. Needham & Company LLC increased their price objective on Hinge Health from $47.00 to $59.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Piper Sandler assumed coverage on Hinge Health in a report on Monday, June 16th. They issued an "overweight" rating and a $41.00 price objective on the stock. Finally, Truist Financial began coverage on Hinge Health in a report on Monday, June 16th. They issued a "buy" rating and a $48.00 price objective on the stock. One analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, Hinge Health has a consensus rating of "Moderate Buy" and a consensus target price of $56.47.

Hinge Health Price Performance

Shares of NYSE HNGE opened at $57.55 on Thursday. Hinge Health has a twelve month low of $33.42 and a twelve month high of $62.18. The firm has a 50-day simple moving average of $51.69.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of HNGE. Montag A & Associates Inc. acquired a new position in shares of Hinge Health in the second quarter valued at $41,000. SBI Securities Co. Ltd. acquired a new position in Hinge Health during the second quarter worth $48,000. PNC Financial Services Group Inc. acquired a new position in Hinge Health during the second quarter worth $71,000. Emerald Advisers LLC acquired a new stake in shares of Hinge Health in the second quarter valued at $108,000. Finally, Mark Sheptoff Financial Planning LLC acquired a new stake in shares of Hinge Health in the second quarter valued at $114,000.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.